Cartilage-binding antibodies induce pain through immune complex–mediated activation of neurons

Male 570 610 Mice, Transgenic Antigen-Antibody Complex Cartilage Oligomeric Matrix Protein Arthritis, Rheumatoid Mice 03 medical and health sciences Immunology in the Medical Area (including Cell and Immunotherapy) Animals Tissues and Organs (q-bio.TO) Collagen Type II Research Articles Autoantibodies Neurons Mice, Inbred BALB C 0303 health sciences Behavior, Animal Receptors, IgG Klinisk medicin Neurosciences Immunology in the medical area Antibodies, Monoclonal Quantitative Biology - Tissues and Organs Arthralgia 3. Good health Mice, Inbred C57BL Disease Models, Animal Cartilage Immunologi inom det medicinska området Quantitative Biology - Neurons and Cognition FOS: Biological sciences Mice, Inbred CBA Female Neurons and Cognition (q-bio.NC) Clinical Medicine
DOI: 10.1084/jem.20181657 Publication Date: 2019-06-13T18:45:16Z
ABSTRACT
Rheumatoid arthritis–associated joint pain is frequently observed independent of disease activity, suggesting unidentified pain mechanisms. We demonstrate that antibodies binding to cartilage, specific for collagen type II (CII) or cartilage oligomeric matrix protein (COMP), elicit mechanical hypersensitivity in mice, uncoupled from visual, histological and molecular indications of inflammation. Cartilage antibody–induced pain-like behavior does not depend on complement activation or joint inflammation, but instead on tissue antigen recognition and local immune complex (IC) formation. smFISH and IHC suggest that neuronal Fcgr1 and Fcgr2b mRNA are transported to peripheral ends of primary afferents. CII-ICs directly activate cultured WT but not FcRγ chain–deficient DRG neurons. In line with this observation, CII-IC does not induce mechanical hypersensitivity in FcRγ chain–deficient mice. Furthermore, injection of CII antibodies does not generate pain-like behavior in FcRγ chain–deficient mice or mice lacking activating FcγRs in neurons. In summary, this study defines functional coupling between autoantibodies and pain transmission that may facilitate the development of new disease-relevant pain therapeutics.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (80)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....